...
首页> 外文期刊>Radiation oncology >In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study
【24h】

In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study

机译:Gafchromic膜的体内剂量法对全骨髓淋巴结的多等中心VMAT照射:可行性研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Total marrow (lymph-nodes) irradiation (TMI-TMLI) by volumetric modulated arc therapy (VMAT) was shown to be feasible by dosimetric feasibility studies. It was demonstrated that several partially overlapping arcs with different isocenters are required to achieve the desired coverage of the hematopoietic or lymphoid tissues targets and to spare the neighbouring healthy tissues. The effect of isocenter shifts was investigated with the treatment planning system but an in- vivo verification of the procedure was not carried out. The objective of this study was the in-vivo verification of the consistency between the delivered and planned doses using bi-dimensional GafChromic EBT3 films. Methods In a first phase a phantom study was carried out to quantify the uncertainties under controlled conditions. In a second phase three patients treated with TMLI were enrolled for in-vivo dosimetry. The dose prescription was 2Gy in single fraction. Ten arcs paired on 4-6 isocenters were used to cover the target. Cone Beam Computed Tomography (CBCT) was used to verify the patient positioning at each isocenter. GafChromic EBT3 films were placed below the patient on the top of a dedicated immobilization system specifically designed. The dose maps measured with the EBT3 films were compared with the corresponding calculations along the patient support couch. Gamma Agreement Index (GAI) with dose difference of 5% and distance to agreement of 5?mm was computed. Results In the phantom study, optimal target coverage and healthy tissue sparing was observed. GAI(5%,5?mm) was 99.4%. For the patient-specific measurements, GAI(5%,5?mm) was greater than 95% and GAI (5%,3?mm)?>?90% for all patients. Conclusions In vivo measurements demonstrated the delivered dose to be in good agreement with the planned one for the TMI-TMLI protocol where partially overlapping arcs with different isocenters are required.
机译:背景技术通过剂量学可行性研究显示,通过容积调制弧光疗法(VMAT)进行的总骨髓(淋巴结)照射(TMI-TMLI)是可行的。已经证明,需要几个具有不同等中心的部分重叠的弧,以实现所需的造血或淋巴组织靶标覆盖,并保留邻近的健康组织。用治疗计划系统研究了等中心线移位的影响,但未对该程序进行体内验证。这项研究的目的是使用二维的GafChromic EBT3胶片进行体内验证,以确认所提供剂量与计划剂量之间的一致性。方法在第一阶段,进行了幻象研究以量化在受控条件下的不确定性。在第二阶段中,招募了三名接受TMLI治疗的患者进行体内剂量测定。剂量处方为单份2Gy。在4-6个等角点上配对的十个弧用于覆盖目标。锥束计算机断层扫描(CBCT)用于验证患者在每个等中心点的位置。将GafChromic EBT3膜放在患者下方,专门设计的专用固定系统的顶部。将EBT3膜测量的剂量图与沿患者支撑床的相应计算进行比较。计算出剂量差异为5%,距离一致距离为5?mm的伽玛一致性指数(GAI)。结果在幻像研究中,观察到最佳靶标覆盖范围和健康的组织备用。 GAI(5%,5?mm)为99.4%。对于患者特定的测量,所有患者的GAI(5%,5?mm)均大于95%,而GAI(5%,3?mm)≥90%。结论体内测量表明,所输送的剂量与TMI-TMLI方案的计划剂量高度吻合,其中要求使用具有不同等中心的部分重叠弧。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号